Valuation : GENFIT

Market Cap 719M 835M 674M 616M 1.16B 79.79B 1.16B 8B 3.12B 40.28B 3.13B 3.07B 134B P/E 2026 *
37.1x
P/E 2027 * 95.5x
Enterprise Value 668M 775M 627M 572M 1.08B 74.12B 1.08B 7.43B 2.9B 37.41B 2.91B 2.85B 124B EV / Sales 2026 *
6.67x
EV / Sales 2027 * 5.27x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.96%
1 week-0.28%
Current month-1.91%
1 month+8.94%
3 months+64.91%
6 months+60.04%
Current year+173.12%
1 week 13.56
Extreme 13.56
14.98
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
05/03/26 Fiscal year

Chief Operating Officer

11,250 0.0225%
05/03/26 Fiscal year

Chief Operating Officer

7,083 0.0142%
05/03/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-0.28%+312.74%+339.08% 835M
-0.78%-1.42%+2.49%+22.78% 50.47B
-6.00%-0.75%+442.41%+544.39% 44.56B
-0.24%+0.74%+38.69%+18.02% 43.08B
-1.55%-2.07%+23.08%+81.47% 41.7B
-0.31%-0.83%+16.15%+51.42% 33.21B
-1.79%-3.24%+27.00%+129.56% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.60%+27.75% 14.58B
-1.66%-1.25%+78.59%+46.66% 13.92B
Average -1.48%-0.98%+105.86%+140.13% 27.54B
Weighted average by Cap. -1.70%-1.06%+96.41%+134.29%

Financials

2026 *2027 *
Net sales 100M 116M 93.94M 85.76M 162M 11.11B 162M 1.11B 435M 5.61B 437M 427M 18.6B 124M 144M 116M 106M 200M 13.76B 201M 1.38B 538M 6.95B 540M 529M 23.03B
Net income 22.88M 26.55M 21.45M 19.58M 36.89M 2.54B 37.01M 254M 99.29M 1.28B 99.68M 97.51M 4.25B 6.8M 7.89M 6.38M 5.82M 10.96M 754M 11M 75.64M 29.51M 381M 29.63M 28.98M 1.26B
Net Debt -51.12M -59.32M -47.93M -43.75M -82.42M -5.67B -82.68M -569M -222M -2.86B -223M -218M -9.49B -66.17M -76.79M -62.04M -56.64M -107M -7.34B -107M -736M -287M -3.7B -288M -282M -12.28B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
28/08/26 €14.38 -0.96% 294,675
27/08/26 €14.52 +2.11% 171,883
26/08/26 €14.22 -0.56% 246,222
25/08/26 €14.30 +2.88% 190,089
24/08/26 €13.90 -3.61% 227,083
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.38EUR
Average target price
15.90EUR
Spread / Average Target
+10.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock